Task: Answer the multiple-choice question.
Query: Which drug exhibits a -5.186\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a.) C/C(=N/NC(=O)c1ccccc1)C(=O)O
b.) N#CCCn1c(-c2nonc2NC(=O)c2ccccc2Cl)nc2ccccc21
c.) O=C(COC(=O)c1cccc(Br)c1)NCCc1ccc(F)cc1
Answer: b. N#CCCn1c(-c2nonc2NC(=O)c2ccccc2Cl)nc2ccccc21
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
N#CCCn1c(-c2nonc2NC(=O)c2ccccc2Cl)nc2ccccc21
N#CCCn1c(-c2nonc2NC(=O)c2ccccc2Cl)nc2ccccc21
2-chloro-N-[4-[1-(2-cyanoethyl)benzimidazol-2-yl]-1,2,5-oxadiazol-3-yl]benzamide